05.17.2015

Romanian medicine producer Biofarm (BIO.RO) reported a net profit of 13.6 million lei (EUR3 million) for the first quarter, up 37.3% from the year earlier period, on higher sales. more

04.07.2015

Romanian drug maker Biofarm Bucuresti (BIO.RO) wants to acquire a pharmaceutical company to gain market share and grow its own business. more

02.12.2015

Sales of pharmaceutical manufacturer Biofarm (BIO.RO) rose 9.5% last year, to RON128.9 million (around EUR29.1 million), while the company's net profit grew 2%, to RON26.1 million (EUR5.9 million. more

11.14.2014

Romanian drugmaker Biofarm (BIO.RO) Friday said its sales rose 4.6% to 89.48 million lei (EUR20.2 million) in the first nine months of 2014, from RON85.57 million in the same period in 2013. more

09.15.2014

The buyback offer launched by pharmaceutical producer Biofarm (BIO.RO) on the Bucharest stock exchange was heavily oversubscribed, as the company’s main shareholders placed orders to sell their more

08.21.2014

Romanian pharmaceutical producer Biofarm (BIO.RO) will buy back up to 10% of its own shares by public offering, at a price of RON0.305/share, thus, the value of the offering might reach RON33.3 more

08.14.2014

Romanian drugmaker Biofarm (BIO.RO) Thursday said its net profit rose 8.9% on the year to 14.74 million lei (EUR3.3 million) in the first half, on higher sales. more

05.14.2014

Romanian pharmaceutical producer Biofarm (BIO.RO) had sales of RON36.78 million in the first quarter, up 10% on the year, and a net profit of RON9.89 million, up 13% on the year, the company said more

05.05.2014

Regional investment companies SIF Muntenia (SIF4.RO) and SIF Banat-Crisana (SIF1.RO), which owns 5% in former, took over 205.2 million Biofarm (BIO.RO) shares from the investors that subscribed in the more

04.04.2014

Romanian regional investment fund SIF Muntenia (SIF4.RO), which controls jointly with SIF Banat-Crisana (SIF1.RO) 54.28% of the shares of pharmaceutical producer Biofarm (BIO.RO), will launch a bid to more

03.26.2014

Zentiva Bucuresti (SCD.RO) is paying the highest dividend of all pharmaceutical producers listed on the Bucharest stock market, while Biofarm (BIO.RO) will not be paying any. Analysts’ favorite, more

03.13.2014

Romanian pharmaceuticals company Biofarm (BIO.RO) targets a net profit of 21.7 million lei (EUR4.8 million) for 2014, down 15% on the year, and RON128 million sales (EUR28.4 million), up 9% more

03.13.2014

Romanian pharmaceuticals company Biofarm (BIO.RO) plans to launch a buyback program for up to 10% of its shares, the company said in a call to its shareholders Thursday. more

03.05.2014

The Romanian Financial Supervisory Authority (ASF) asked regional investment funds SIF Muntenia (SIF4.RO) and SIF Banat-Crisana (SIF1.RO) to launch a takeover bid for pharmaceutical producer Biofarm more

02.14.2014

Romanian pharmaceutical producer Biofarm (BIO.RO) Friday reported a preliminary net profit of 25.61 million lei (EUR5.8 million) for 2013, up 21.7% on the year, fueled by rising sales. more

01.05.2014

In 2013 all eyes were on the Health Ministry as far as the healthcare system is concerned, while the private sector came with several surprise transactions. more

11.11.2013

Romanian pharmaceutical company Biofarm (BIO.RO) said Monday it registered sales of 85.5 million lei (EUR19.4 million) in the first nine months of 2013, up about 11% on the year, and 7% higher profit more

11.03.2013

Romanian pharmaceutical company Biofarm (BIO.RO) will double its production capacity and will enter new therapy areas with its relocation to a new plant in 2015, and plans to focus on developing more

10.24.2013

Romanian regional investment fund SIF Muntenia (SIF4.RO) Thursday bought 3.2% (or 35 million shares) in medicine producer Biofarm (BIO.RO) for 10.67 million lei (EUR2.4 million). more

10.23.2013

Romanian regional investment fund SIF Oltenia (SIF5.RO) Wednesday sold its entire stake (28.77%) in medicine producer Biofarm Bucuresti (BIO.RO) in a special deal worth 96.07 million lei (EUR21.6 more

10.03.2013

The shares of drug producers Antibiotice Iasi (ATB.RO) and Biofarm Bucuresti (BIO.RO) generated over 50% profits in the past year, including the dividends paid to shareholders, which makes them some more

08.14.2013

Romanian drugmaker Biofarm (BIO.RO) Wednesday said its net profit rose 10.3% on the year to 13.53 million lei (EUR3 million) in the first half of 2013, and its sales grew at a similar pace to RON58.44 more

05.14.2013

Romanian drugmaker Biofarm (BIO.RO) Tuesday said its net profit rose 32% on the year to 8.7 million lei (EUR2 million) in the first quarter, on higher sales. more

03.15.2013

Romanian drug maker Biofarm (BIO.RO) Friday said it forecasts 10% higher sales in 2012, to 115.1 million lei (EUR26.2 million), from RON105 million a year before. more

03.14.2013

The managing board of Romanian drug maker Biofarm (BIO.RO) Thursday proposed paying out its shareholders dividends of 14.2 million lei (EUR3.2 million) from the profit registered in 2012, up 30% on more